Bruker Corp (BRKR) reports a 14.6% increase in Q4 revenue and sets optimistic guidance for 2025 despite challenges in Asia ...

Corporation reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $0.76 against the forecast of $0.74. Revenue also exceeded projections, ...

Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2024. Frank H. Laukien, Bruker's ...

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales reorganization and grow base of industry users.

Bruker’s BRKR strong growth reflects its ... In May 2024, the company purchased NanoString Technologies’ assets, bringing innovative platforms and solutions for spatial transcriptomics and ...

Bruker ’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and its ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...

Bruker Corporation (NASDAQ: BRKR) is undervalued, trading below its fair value of $74, offering significant upside potential due to its strategic acquisitions and improving book value per share ...